OSF HEART OF MARY MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4.6M
- Transactions
- 607
- Companies
- 40
- Average per transaction
- $7,616
Who reported the payments
| Regeneron | $925,398 |
| Janssen Research & Development, LLC | $488,886 |
| UCB SA | $457,726 |
| Cardiofocus, Inc. | $351,500 |
| Alkermes, Inc. | $246,938 |
| AbbVie | $210,232 |
| Davol Inc. | $174,621 |
| Pfizer | $150,805 |
| ZOLL Medical Corporation | $149,134 |
| Sanofi US Services Inc. | $140,765 |
| Galvanize Therapeutics, Inc | $132,615 |
| E.r. Squibb & Sons, L.L.C. | $99,322 |
| Harmony Biosciences LLC | $92,518 |
| Gilead | $81,265 |
| Smith+Nephew | $79,694 |
| Ardelyx, Inc. | $73,674 |
| Occlutech US LLC | $67,888 |
| Takeda Pharmaceuticals U.S.A., Inc. | $67,378 |
| Vifor (international) Ltd. | $60,573 |
| Roche Products Limited | $59,073 |
| Johnson & Johnson | $56,491 |
| Endotronix, Inc. | $52,809 |
| Medical Device Business Services, Inc. | $44,734 |
| Angiodynamics, Inc. | $43,667 |
| Sanofi | $31,965 |
| Biogen | $30,321 |
| Abbott | $29,193 |
| Mitsubishi Tanabe Pharma Development America, Inc. | $27,195 |
| Siemens Medical Solutions USA, Inc. | $24,653 |
| BD | $23,720 |
| Vifor Pharma, Inc. | $19,016 |
| Catalyst Pharmaceuticals, Inc. | $14,113 |
| Penumbra, Inc. | $13,700 |
| Chiesi USA, Inc. | $12,500 |
| Tanabe Pharma America, Inc. | $10,175 |
| GE HealthCare | $8,930 |
| Stryker | $8,676 |
| Surmodics, Inc. | $8,498 |
| F. Hoffmann-la Roche AG | $6,238 |
| Medline Industries LP | $5,000 |